TrueNorth Lifesciences take a unique multi-dimensional approach toward life investing, evaluating not only the scientific, clinical and regulatory risks (i.e., likelihood of technical success) but also carefully evaluating commercial risk and opportunity (i.e., likelihood and magnitude of commercial success) across global markets.
For highly innovative early and mid-stage life science companies, TrueNorth Lifesciences provides strategic consulting and financial advisory services to accelerate and optimize drug, device and medical diagnostic development and commercialization. We differentiate based on our unique ability to optimize and align R&D / commercialization strategies with customized and creative approaches to financing.
TrueNorth Lifesciences also works with a select network of elite family offices, hedge funds and high net worth / ultra-high net worth individuals providing buy-side advisory services on healthcare and biotech-related investments.